A new type of therapy called Immunotherapy, is used to treat cancers. It’s been observed that Immunotherapy could lead to an over-activation of the immune system. In Rheumatology we’re seeing an increase in arthritis driven by this activation of the immune system. Dr. Cappelli discusses the questions she and her oncologist colleagues have about why this happens and how do we best evaluate and treat these patients.
Research
Biologic Medications and Cancer Risk
Research Update Series: Improving Immunization Rates Among Adults with Rheumatic Diseases
Nurse Vicky Ruffing and Dr. Erika Darrah speak about the existing barriers of immunizations, as well as why it is so important for people with a rheumatic disease to keep up to date with their vaccines.
Research Update Series: Sjögren’s Syndrome in Relation to Central Nervous System Disorders
Dr. Susan Bartlett on What Factors Contribute to Fatigue in Rheumatoid Arthritis
Dr. Bartlett shares a recent research update on fatigue and Rheumatoid Arthritis.
Abstract Link
Pain, Physical Function, and Worry (But Not Depression and Poor Sleep) Lead to Greater Fatigue in RA
Dr. Laura Cappelli on Rheumatologic Consequences of Immunotherapy to Treat Certain Cancers
Dr. Cappelli’s research interest involves collaboration with oncologists to study patients developing rheumatic diseases after being treated for their cancer by a new oncology drug.
Abstract Link
Rheumatologic Consequences of Immunotherapy to Treat Malignancies: The Tip of an Iceberg